About Us

Discover more about the growth of the DDF Summit

The DDF Summit has built a reputation on high-quality content. We build our programme around the most pertinent and exciting topics, researching the market and the latest drug approvals to determine the most interesting topics. Our expert scientific advisory board advise on the content and speakers for the agenda each year, and help to ensure that this is as high-quality and relevant as possible. We also use industry surveys and feedback from attendees to hear directly from our audience what topics they would like to see on the agenda.

Originally a two-day and two-stream event focusing on Small Devices and Biologics, the summit grew to add our Technology & Innovation stream in 2012, addressing growing and shifting market needs. In 2015, a fourth stream Device Development was introduced to reflect the increasing demand for patient-centric medicine. With the American DDF Summit well established, the conference continues to go from strength to strength as we look to launch new events in new regions.

The Global DDF Team is part of Mark Allen Group, one of the UK’s leading independent publishing and event companies, based in London.

Moving to its 16th year, the Global Drug Delivery and Formulation Summit is established as the premier pharmaceutical events for drug delivery, formulation and device professionals.
With over 100 scientific presentations, over 90 senior industry speakers and 4 streams across a  3 day agenda and a poster presentation competition, the Global DDF Summit provides innovative solutions to challenges in pharmaceutical development. Located in Berlin at the Maritim ProArte Hotel, the summit is at heart of the pharmaceutical industry in Europe with easy connections across the continent.

Since the first summit in 2009, the summit has grown in size and scope to accommodate our expanding audience and to align with ongoing industry developments and new challenges. With over 400 attendees in 2022 and even more expected in 2023, the summit attracts senior pharmaceutical leaders. Our expansive agenda is built around four key content streams, aiming to encompass all of the main industry areas.
⬛️ Small Molecules

⬛️ Biologics

⬛️ Technology & Innovation

⬛️ Device Development